Prof. Su Qi is a distinguished specialist in molecular biology and bioinformatics with extensive experience in the gut microbiome and its relationship to human diseases. He excels in analyzing large multi-omics datasets for both clinical and research applications. He has authored over 50 original research papers in high-impact journals, such as Cell, Nature Medicine, Nature Microbiology, Cell Host & Microbe, and Lancet Infectious Diseases. Recognized for his significant contributions, Dr. Su has secured several competitive grants and numerous awards, notably FDA breakthrough device designation and Young Scientist Award from Hong Kong Institute of Science. Additionally, he serves on the editorial board of iMeta and reviews for peer-reviewed journals including Nature Methods, Advanced Science and Gut.
Prof. Su Qi is a distinguished specialist in molecular biology and bioinformatics with extensive experience in the gut microbiome and its relationship to human diseases. He excels in analyzing large multi-omics datasets for both clinical and research applications. He has authored over 50 original research papers in high-impact journals, such as Cell, Nature Medicine, Nature Microbiology, Cell Host & Microbe, and Lancet Infectious Diseases. Recognized for his significant contributions, Dr. Su has secured several competitive grants and numerous awards, notably FDA breakthrough device designation and Young Scientist Award from Hong Kong Institute of Science. Additionally, he serves on the editorial board of iMeta and reviews for peer-reviewed journals including Nature Methods, Advanced Science and Gut.